Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000902664-25-003509
Filing Date
2025-08-12
Accepted
2025-08-12 09:05:28
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 10652
  Complete submission text file 0000902664-25-003509.txt   12421
Mailing Address 100 MARINE PARKWAY, SUITE 400 REDWOOD CITY CA 94065
Business Address 100 MARINE PARKWAY, SUITE 400 REDWOOD CITY CA 94065 650-213-8444
SOLENO THERAPEUTICS INC (Subject) CIK: 0001484565 (see all company filings)

EIN.: 770523891 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-88637 | Film No.: 251204580
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 200 CLARENDON STREET, 52ND FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET, 52ND FLOOR BOSTON MA 02116 617-867-2800
Adage Capital Management, L.P. (Filed by) CIK: 0001535978 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A